Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: clinical trial phase compliance

Selecting the Right Candidates for Phase 0: Drug Selection Criteria

Posted on May 14, 2025 digi By digi

Selecting the Right Candidates for Phase 0: Drug Selection Criteria How to Choose the Right Drug Candidates for Phase 0 Clinical Trials Why Drug Selection Matters in Phase 0 Trials Not every drug candidate is suitable for a Phase 0 microdosing study. These trials are designed to generate early pharmacokinetic (PK) and pharmacodynamic (PD) data…

Read More “Selecting the Right Candidates for Phase 0: Drug Selection Criteria” »

Preclinical Studies

How to Design a Microdosing Study in Phase 0 Trials

Posted on May 14, 2025 digi By digi

How to Design a Microdosing Study in Phase 0 Trials A Step-by-Step Guide to Designing a Microdosing Study for Phase 0 Trials What is a Microdosing Study? A microdosing study involves the administration of extremely low, sub-therapeutic doses of a drug to human subjects to evaluate early pharmacokinetic (PK) and pharmacodynamic (PD) behavior. These studies…

Read More “How to Design a Microdosing Study in Phase 0 Trials” »

Preclinical Studies

Introduction to Phase 0 Trials: Objectives, Design, and Rationale

Posted on May 13, 2025 digi By digi

Introduction to Phase 0 Trials: Objectives, Design, and Rationale Understanding Phase 0 Trials: Purpose, Design, and Why They Matter What are Phase 0 Clinical Trials? Phase 0 trials, also known as microdosing studies, are the earliest phase of human clinical research. Introduced as part of an exploratory IND (Investigational New Drug) framework by the U.S….

Read More “Introduction to Phase 0 Trials: Objectives, Design, and Rationale” »

Preclinical Studies

GLP Compliance in Preclinical Research Laboratories

Posted on May 13, 2025 digi By digi

GLP Compliance in Preclinical Research Laboratories Ensuring GLP Compliance in Preclinical Research Laboratories What is Good Laboratory Practice (GLP)? Good Laboratory Practice (GLP) is a quality system concerned with the organizational processes and conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived, and reported. It ensures the reliability and…

Read More “GLP Compliance in Preclinical Research Laboratories” »

Preclinical Studies

Ethical Considerations in Preclinical Animal Testing

Posted on May 13, 2025 digi By digi

Ethical Considerations in Preclinical Animal Testing Ensuring Ethics in Animal Testing During Preclinical Research Why Ethics Matter in Preclinical Animal Testing Animal studies are essential for evaluating the safety and efficacy of new drugs before human trials. However, their use comes with significant ethical responsibility. Animals are sentient beings, and using them in research must…

Read More “Ethical Considerations in Preclinical Animal Testing” »

Preclinical Studies

Translational Science: Bridging Preclinical and Clinical Research

Posted on May 12, 2025 digi By digi

Translational Science: Bridging Preclinical and Clinical Research How Translational Science Connects Preclinical Research to Clinical Practice What is Translational Science? Translational science refers to the process of turning laboratory discoveries and preclinical findings into therapeutic interventions that can be tested and used in humans. It forms the critical bridge between basic science and clinical application,…

Read More “Translational Science: Bridging Preclinical and Clinical Research” »

Preclinical Studies

Preclinical Study Design Best Practices

Posted on May 12, 2025 digi By digi

Preclinical Study Design Best Practices A Guide to Best Practices in Designing Preclinical Studies Introduction: Why Study Design Matters in Preclinical Research The quality of a preclinical study depends heavily on its design. A well-structured study can offer reliable, reproducible, and regulatory-acceptable data that supports the transition of a drug into human trials. Poorly designed…

Read More “Preclinical Study Design Best Practices” »

Preclinical Studies

ADME Studies: Understanding Drug Behavior Before Clinical Trials

Posted on May 12, 2025 digi By digi

ADME Studies: Understanding Drug Behavior Before Clinical Trials Exploring ADME Studies: How Drugs Behave Before Clinical Trials Begin What Are ADME Studies in Preclinical Research? ADME stands for Absorption, Distribution, Metabolism, and Excretion—a core set of pharmacokinetic processes that describe what the body does to a drug. Understanding these parameters is essential before any new…

Read More “ADME Studies: Understanding Drug Behavior Before Clinical Trials” »

Preclinical Studies

Regulatory Guidelines for Preclinical Studies (FDA, EMA, CDSCO)

Posted on May 11, 2025 digi By digi

Regulatory Guidelines for Preclinical Studies (FDA, EMA, CDSCO) Understanding Preclinical Study Guidelines by FDA, EMA, and CDSCO Why Regulatory Guidelines Matter in Preclinical Studies Before initiating clinical trials in humans, pharmaceutical companies must conduct comprehensive preclinical studies in compliance with international and national regulatory guidelines. These regulations ensure that the data generated is reliable, reproducible,…

Read More “Regulatory Guidelines for Preclinical Studies (FDA, EMA, CDSCO)” »

Preclinical Studies

Role of Animal Models in Predicting Human Outcomes

Posted on May 11, 2025 digi By digi

Role of Animal Models in Predicting Human Outcomes How Animal Models Help Predict Drug Outcomes in Humans Introduction: Why Animal Models Are Crucial in Drug Development Animal models serve as indispensable tools in the drug development process. Before a drug ever reaches a human subject, researchers need to understand how it behaves in a complex…

Read More “Role of Animal Models in Predicting Human Outcomes” »

Preclinical Studies

Posts pagination

Previous 1 … 5 6 7 Next

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
  • Clinical Trial Design and Protocol Development
  • Good Clinical Practice (GCP) and Compliance
  • U.S. FDA Regulations

Menu

Recent Posts

  • Step-by-Step Guide to Regulatory Submissions for Phase 0 Trials
  • Real-World Evidence (RWE) Generation from Phase 4 Clinical Trials
  • Global Phase 3 Trial Design: Conducting Multi-Regional Clinical Trials (MRCTs)
  • Dose-Ranging and Dose-Finding Strategies in Phase 2
  • Sentinel Dosing in First-in-Human Studies: Why and How It’s Done

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme